今日观察！A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.

网易云音乐致歉华晨宇粉丝：活动失误将补偿

北京 - 2024年6月7日，网易云音乐就华晨宇音乐专辑《希忘Hope》线下打卡活动出现失误发布致歉声明。声明中称，由于部分万达广场大屏投放系统技术问题和临时检修，导致华晨宇音乐专辑USB版《希忘Hope》大屏宣传内容在多地延迟或无法按时展示。

网易云音乐对由此给华晨宇粉丝造成的不便表示诚挚歉意，并承诺将采取以下措施进行补偿：

• 追加推广资源：为华晨宇音乐专辑《希忘Hope》增加线上线下推广资源，包括但不限于微博、微信、抖音等平台的推广，以及户外广告、电台宣传等。
• 增设投放区域：将华晨宇音乐专辑《希忘Hope》大屏宣传内容投放至更多城市和地区的万达广场。
• 演唱会线下宣传：在华晨宇即将举办的演唱会现场进行线下宣传，为粉丝提供购票优惠和专属福利。

网易云音乐表示，将吸取此次教训，加强活动管理，杜绝类似事件再次发生，并继续为用户提供优质的服务。

事件回顾

6月6日，网易云音乐在全国多地万达广场的大屏上投放了华晨宇音乐专辑《希忘Hope》的宣传内容。然而，有粉丝反映，部分地区的宣传内容出现延迟或无法展示。

粉丝反应

华晨宇粉丝对网易云音乐的失误表示不满，并要求平台进行道歉和补偿。有粉丝表示，他们特意前往万达广场观看宣传内容，但却没有看到，感到非常失望。

网易云音乐回应

网易云音乐在接到粉丝投诉后，立即进行了调查，并于6月7日发布致歉声明。网易云音乐表示，他们已经意识到问题的严重性，并将采取措施进行整改。

业内人士分析

业内人士认为，网易云音乐此次活动失误，是由于前期准备不足和应急机制不完善造成的。他们建议网易云音乐在以后举办活动时，要加强事前策划和风险评估，并制定完善的应急预案，以避免类似事件再次发生。